OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A trimeric NTD and RBD SARS-CoV-2 subunit vaccine induced protective immunity in CAG-hACE2 transgenic mice and rhesus macaques
Jiaping Yu, Wenrong Yao, Yingsong Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 7
Jiaping Yu, Wenrong Yao, Yingsong Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 7
Showing 7 citing articles:
Immunobiology and immunotherapy of COVID-19
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
COVID-19 Vaccines: Where Do We Stand at the End of 2023?
Kenneth Lundström
(2024)
Open Access | Times Cited: 3
Kenneth Lundström
(2024)
Open Access | Times Cited: 3
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
Simona Dedoni, Valeria Avdoshina, Chiara Camoglio, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4142-4142
Open Access | Times Cited: 14
Simona Dedoni, Valeria Avdoshina, Chiara Camoglio, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4142-4142
Open Access | Times Cited: 14
Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies
Abundio Balgos, Suad Hannawi, Wenli Chen, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 419-431
Open Access
Abundio Balgos, Suad Hannawi, Wenli Chen, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 419-431
Open Access
Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies
Chris Wynne, Abundio Balgos, Jingxin Li, et al.
Infectious Diseases and Therapy (2023) Vol. 13, Iss. 1, pp. 57-78
Open Access | Times Cited: 1
Chris Wynne, Abundio Balgos, Jingxin Li, et al.
Infectious Diseases and Therapy (2023) Vol. 13, Iss. 1, pp. 57-78
Open Access | Times Cited: 1
Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
Altijana Hromić‐Jahjefendić, Kenneth Lundström, Muhamed Adilović, et al.
Autoimmunity Reviews (2023) Vol. 23, Iss. 3, pp. 103508-103508
Closed Access | Times Cited: 1
Altijana Hromić‐Jahjefendić, Kenneth Lundström, Muhamed Adilović, et al.
Autoimmunity Reviews (2023) Vol. 23, Iss. 3, pp. 103508-103508
Closed Access | Times Cited: 1
The preliminary safety and immunogenicity results of a randomized, double-blind, placebo-controlled Phase I trial for a recombinant two-component subunit SARS-CoV-2 vaccine ReCOV
Chris Wynne, Paul Hamilton, Jingxin Li, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Chris Wynne, Paul Hamilton, Jingxin Li, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
